Digital transformation is no longer a “future goal” for cell and gene therapy—it is a present-day necessity. At Meeting on the Mesa 2025, Autolomous CEO, Alexander Seyf, sat down with IBTV to discuss a groundbreaking collaboration that is set to redefine decentralized manufacturing.

The Digital Pioneer Program brings together Autolomous, Adva Biotechnology, and GenCART to create a fully integrated, end-to-end digital ecosystem for cell therapies.